Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Haas

Showing results (391-400 of 542) with videos related to

Pageof 55
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapyTodd Hulgan, John P Donahue, Charlene Hawkins, et al.
The Journal of Infectious Diseases|November 14, 2012
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202Heather J Ribaudo, Eric S Daar, Camlin Tierney, et al.
The Journal of Infectious Diseases|May 4, 2004
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment responseDonna Mildvan, Ronald J Bosch, Ryung S Kim, et al.
AIDS Research and Human Retroviruses|December 12, 2019
Mitochondrial DNA Haplogroups and Frailty in Adults Living with HIVKristine M Erlandson, Yuki Bradford, David C Samuels, et al.
Journal of Clinical Microbiology|April 3, 2001
Comparison of Roche MONITOR and Organon Teknika NucliSens assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluidP Spearman, S A Fiscus, R M Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 22, 2017
Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based RegimensJamison Norwood, Megan Turner, Carmen Bofill, et al.
Pharmacogenetics and Genomics|April 26, 2023
Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern AfricansSomila Mateza, Yuki Bradford, Gary Maartens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 4, 2015
Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South AfricaChristopher J Hoffmann, Silvia Cohn, Fildah Mashabela, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 21, 2022
Leveraging Multi-Ancestry Polygenic Risk Scores for Body Mass Index to Predict Antiretroviral Therapy-Induced Weight GainKarl Keat, Daniel Hui, Brenda Xiao, et al.
Pharmacogenetics and Genomics|November 1, 2023
Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimensKunling Wu, John Koethe, Todd Hulgan, et al.
Pageof 55

Showing results (391-400 of 542) with videos related to

Sort By:
Pageof 55
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapyTodd Hulgan, John P Donahue, Charlene Hawkins, et al.
The Journal of Infectious Diseases|November 14, 2012
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202Heather J Ribaudo, Eric S Daar, Camlin Tierney, et al.
The Journal of Infectious Diseases|May 4, 2004
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment responseDonna Mildvan, Ronald J Bosch, Ryung S Kim, et al.
AIDS Research and Human Retroviruses|December 12, 2019
Mitochondrial DNA Haplogroups and Frailty in Adults Living with HIVKristine M Erlandson, Yuki Bradford, David C Samuels, et al.
Journal of Clinical Microbiology|April 3, 2001
Comparison of Roche MONITOR and Organon Teknika NucliSens assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluidP Spearman, S A Fiscus, R M Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 22, 2017
Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based RegimensJamison Norwood, Megan Turner, Carmen Bofill, et al.
Pharmacogenetics and Genomics|April 26, 2023
Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern AfricansSomila Mateza, Yuki Bradford, Gary Maartens, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 4, 2015
Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South AfricaChristopher J Hoffmann, Silvia Cohn, Fildah Mashabela, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 21, 2022
Leveraging Multi-Ancestry Polygenic Risk Scores for Body Mass Index to Predict Antiretroviral Therapy-Induced Weight GainKarl Keat, Daniel Hui, Brenda Xiao, et al.
Pharmacogenetics and Genomics|November 1, 2023
Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimensKunling Wu, John Koethe, Todd Hulgan, et al.
Pageof 55